Zarrabi, K. K., Slovin, S. F., Tester, W. J., Leiby, B. E., Pileggi, S., Knudsen, K. E., Smith, D. C., Chatta, G. S., Autio, K. A., Abida, W., Scher, H. I., Morris, M. J., Kelly, W. K. (2026). A randomized phase Ib/II study of enzalutamide (Enza) with and without ribociclib (Rib) in patients with metastatic castrate-resistant prostate cancer (mCRPC) that retains RB expression: RiboX study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5057